Rapid Communication
Copyright ©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2007; 13(46): 6208-6212
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6208
Table 3 Demographics and results for control and study groups (Classified as mild and severe AP)
ControlMild APSevere APP1P2P3
(n = 25)(n = 66)(n = 26)
Age (yr)459.2 ± 13.558.7 ± 14.360.2 ± 14.90.8830.7960.655
Gender (F/M)15/1051/1517/90.1180.7760.365
BMI (kg/m2)423.5 ± 3.423.5 ± 3.924.2 ± 4.10.6270.5070.217
Amylase (> 100 U/L)467 ± 32.5578.6 ± 171658.2 ± 2220.0000.0000.068
Lipase (> 60 U/L)433.8 ± 176.0 ± 23.9110.4 ± 54.20.0000.0000.000
Positive UTDT2/2361/526/00.0000.0000.351
(on admission)
Positive UTDT1/2461/526/00.0000.0030.351
(48 h later)
Duration of UTDT positivity (d)42.0 ± 1.42.6 ± 0.66.2 ± 2.50.0000.0000.000
APACHE-II score4.6 ± 1.54.7 ± 1.49.7 ± 1.80.8070.0000.000
(on admission)4
APACHE-II score-4.24 ± 1.411.5 ± 2.9--0.000
(after 48 h)4
Ranson score-1.03 ± 0.83.73 ± 1--0.000
(on admission) > 24